REGINA DUPIGNY: Open Payments
NPI 1689145096 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 14 payments from 8 companies in 2025. Trend: 2023 $307 · 2024 $224 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $74 |
| Globus Medical, Inc. | 2 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Novo Nordisk Inc | 2 | $59 |
| Amgen Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| TMS NeuroHealth Centers Inc. | 1 | $9 |
Products named: MOUNJARO, Senza, AIRSUPRA, REPATHA, INGREZZA, GARDASIL 9, TMS NeuroHealth Centers Inc..
Industry payments across MD — which companies pay providers there.
